Aveanna Healthcare Balances Big 2025 Gains With Cautious 2026

Aveanna Healthcare Holdings Inc ((AVAH)) has held its Q4 earnings call. Read on for the main highlights of the call.

Aveanna Healthcare’s latest earnings call struck an optimistic but measured tone as management highlighted powerful operational momentum while openly acknowledging emerging headwinds. Double‑digit revenue and EBITDA growth, expanding margins in core businesses, and strong cash generation framed the discussion, but executives stressed that some 2025 benefits are non‑recurring and that labor, reimbursement, and debt costs remain key watchpoints.

Strong Top-Line Growth

Aveanna delivered standout top-line performance, powered by broad-based volume and pricing gains across its service lines. Fourth-quarter revenue climbed 27.4% year over year to $662.5 million, while full-year 2025 revenue reached $2.433 billion, up 20.2%, with management noting that the 53rd week added an extra boost to the annual figures.

Substantial EBITDA Expansion

Profitability improved even faster than revenue as cost discipline and mix upgrades flowed through the income statement. Adjusted EBITDA surged 54% year over year to $85 million in the fourth quarter and jumped 74.8% for the full year to $320.8 million, underscoring the operating leverage embedded in the model despite elevated wage and inflation pressures.

Private Duty Services Drives Core Growth

Private Duty Services remained the company’s engine, combining higher volume with meaningful rate gains. PDS fourth-quarter revenue was approximately $541 million, up 28.1% year over year, on 12.4 million care hours, up 17.9%, while revenue per hour rose 10.2% to $43.74 and gross margin reached 27.7%, supported by a spread per hour of $12.12.

Home Health & Hospice Momentum

Home Health and Hospice also posted robust growth as Aveanna leaned into episodic payers and favorable mix. Fourth-quarter revenue rose 27.3% to $69.3 million, driven by 10,400 admissions and 14,000 episodes, with episodic payers accounting for 78% of mix, Medicare revenue per episode at $3,223, and a strong gross margin of 53.7%.

Medical Solutions Growth With Caveats

Medical Solutions delivered solid top-line gains but with some non-recurring uplift that will fade in coming quarters. Revenue grew 21.3% year over year to $52.5 million on about 92,000 unique patients, while revenue per patient rose 17.9% to roughly $570 and gross margin hit 50%, aided by a reserve release that management expects to normalize away.

Preferred Payer Strategy Builds Pricing Power

Management underscored preferred payer expansion as a central pillar for sustainable margin improvement across the portfolio. In PDS, the company added eight preferred agreements in 2025 to reach 30, with these contracts representing about 57% of managed-care volume and a target in the low-60% range for 2026, while home health reached 45 preferred payers and Medical Solutions ended the year at 18.

Robust Liquidity and Cash Generation

The balance sheet and cash profile give Aveanna room to navigate volatility while investing for growth. Quarter-end liquidity stood at $529 million, including roughly $193 million of cash, $110 million of securitization availability, and $226 million of undrawn revolver capacity, and for the full year the company produced $125.9 million in operating cash flow and $131 million in free cash flow.

Strategic M&A: Family First Acquisition

Aveanna is selectively using M&A to deepen its footprint in attractive markets while keeping leverage in check. The announced $175.5 million acquisition of Family First Home Care, which brings about $120 million of revenue and is priced at roughly 7.5 times post-synergy EBITDA, is expected to close in the second quarter of 2026 with cash and securitization funding and minimal near-term leverage impact.

Conservative 2026 Guidance and Growth Moderation

Guidance for 2026 reflects a reset after an outsized 2025, with management prioritizing realism over headline growth. The company projected revenue of $2.54 billion to $2.56 billion and adjusted EBITDA of $318 million to $322 million, excluding Family First, implying mid-single-digit revenue growth and roughly flat EBITDA once one-time items and Medical Solutions normalization are factored in.

One-Time Benefits and Normalizing Margins

Executives were explicit that some 2025 tailwinds will not repeat, tempering expectations for the year ahead. The 53rd week provided an extra period of volume and earnings, and Medical Solutions booked a $2.5 million to $3 million reserve release that elevated fourth-quarter revenue and EBITDA, with segment margins expected to normalize toward 43% to 45% in the first quarter.

Caregiver Labor and Wage Pressures

The company continues to grapple with a tight caregiver labor market that is pushing up wages and squeezing spreads, particularly in PDS. Cost of revenue per hour in Private Duty Services rose 11.1% year over year to $31.62, narrowing the margin between hourly reimbursement and labor costs, though Aveanna is actively managing wage pass-throughs and mix to protect profitability.

California Reimbursement Headwinds

California remains a troublesome geography for Aveanna, with little relief in sight from state budget dynamics. Management does not expect a significant private duty nursing rate increase in the state’s 2026–2027 budget cycle and assigns a low probability of improvement in the upcoming budget update, viewing California as a shrinking and structurally challenging contributor in PDS.

Medical Solutions Near-Term Volatility

Investors should brace for a softer near-term trajectory in Medical Solutions before more durable growth emerges. After the reserve release-fueled margin jump in the fourth quarter, management anticipates mid-single-digit revenue growth and normalized margins in early 2026, with a transition to double-digit growth only by late 2026 as modernization efforts and payer realignment take hold.

Managing Variable-Rate Debt Exposure

Aveanna’s sizable variable-rate debt stack remains a risk factor, though hedges meaningfully reduce near-term rate shocks. The company reported roughly $1.49 billion of variable-rate obligations, offset by $520 million in swaps and $880 million in interest caps, and highlighted upcoming hedge expirations through mid-2026 and early-2027 as key timing considerations for interest expense.

Seasonality and Early-2026 Friction

Management reminded investors that the first quarter is seasonally weak for both operating and free cash flow, largely due to payroll tax timing. The company also flagged weather-related disruptions early in 2026, including localized snow events, but characterized these as operational nuisances rather than material threats to the full-year outlook.

Forward-Looking Outlook and Strategic Priorities

Looking ahead, Aveanna’s guidance envisions steady but more modest growth while it shores up its payer mix and capital structure. The company expects 2026 free cash flow roughly in line with 2025 and leverage around four times, while it pushes preferred payer penetration higher across all segments, targets incremental government rate wins in several states, and integrates Family First once the deal closes to extend its growth runway beyond the current year.

Aveanna’s earnings call painted a picture of a company transitioning from a breakout year into a more normalized, execution-focused phase, balancing strong momentum with realistic caution. For investors, the story now hinges on how effectively management can expand preferred payer relationships, manage labor and reimbursement pressures, and deploy capital into high-return acquisitions while keeping leverage contained.